The effects of 3- -dimethylaminopropyl-3-phenylphthalide (I.C.I. 53,165) on brain monoamines and their precursors.
D000818:Animals; D000927:Anticonvulsants / Q000494:pharmacology; D001555:Benzene Derivatives / Q000494:pharmacology; D001572:Benzofurans / Q000494:pharmacology* / Q000633:toxicity; D001679:Biogenic Amines / Q000378:metabolism*; D001831:Body Temperature / Q000187:drug effects; D001921:Brain / Q000187:drug effects* / Q000378:metabolism; D003913:Dextroamphetamine / Q000633:toxicity; D004123:Dimethylamines / Q000494:pharmacology; D004597:Electroshock; D006591:Hexobarbital / Q000494:pharmacology; D007659:Ketones / Q000494:pharmacology; D007928:Lethal Dose 50; D008781:Methyltyrosines / Q000494:pharmacology; D051379:Mice; D009638:Norepinephrine / Q000378:metabolism; D010095:Oxotremorine / Q000037:antagonists & inhibitors; D010433:Pentylenetetrazole / Q000037:antagonists & inhibitors; D051381:Rats; D012110:Reserpine / Q000494:pharmacology; D012472:Salivation / Q000187:drug effects; D012701:Serotonin / Q000032:analysis; D012890:Sleep / Q000187:drug effects; D014439:Tyramine / Q000494:pharmacology
D000927:Anticonvulsants; D001555:Benzene Derivatives; D001572:Benzofurans; D001679:Biogenic Amines; D004123:Dimethylamines; D007659:Ketones; D008781:Methyltyrosines; D012701:Serotonin; D010095:Oxotremorine; D012110:Reserpine; D006591:Hexobarbital; D003913:Dextroamphetamine; D010433:Pentylenetetrazole; D009638:Norepinephrine; D014439:Tyramine